Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
A severe hereditary bleeding disorder was described in a large family from east Texas in 2001.
The affected family members routinely had bruising, nosebleeds, massive blood loss following injury or surgery, and often required blood transfusions.
Routine tests for functional components of the blood coagulation pathway did not reveal any obvious defects. Genomic sequencing revealed a mutation in the gene encoding coagulation factor 5 (FV), but it was not considered to contribute to disease, since clotting assays were normal.
In this issue of the Journal of Clinical Investigation, Björn Dahlbäck and colleagues at Lund University reveal that this mutation results in a truncated form of FV. This truncated FV was present in plasma from all affected family members. The authors demonstrate that truncated FV forms a complex with tissue factor pathway inhibitor-α (TFPI) that inhibits coagulation pathways.
In the accompanying commentary, George Brooze and Thomas Girard at Washington University suggest that treatment of family members with the Texas bleeding disorder with TFPI inhibitors may relieve symptoms of the disorder.
TITLE: Coagulation factor VA2440G causes east Texas bleeding disorder via TFPIα J Clin Invest. doi:10.1172/JCI69091.
ACCOMPANYING COMMENTARY TITLE: Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder J Clin Invest. 2013;123(9):3710-3712. doi:10.1172/JCI71220.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Blood / Hematology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Journal of Clinical Investigation. "Genomic sequencing leads to discovery of origin of hereditary east Texas bleeding disorder." Medical News Today. MediLexicon, Intl., 29 Aug. 2013. Web.
9 Dec. 2013. <http://www.medicalnewstoday.com/releases/265314>
Journal of Clinical Investigation. (2013, August 29). "Genomic sequencing leads to discovery of origin of hereditary east Texas bleeding disorder." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/265314.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.